GL1X · GenesisL1 explorer

MolNFT v1 · #74073 · protein

Crystal structure of the GLUK5 (KA2) atd crystallographic dimer at 1.4 ångström resolution

3OM0 · Glutamate receptor, ionotropic kainate 5: “Crystal structure of the GLUK5 (KA2) atd crystallographic dimer at 1.4 ångström resolution”. X-ray diffraction, 2 ligands (NAG, BMA), 5 pockets (best druggability 0.72). MolNFT v1 #74073 on…

PDB
3OM0
Type
protein
Length
369 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glutamate receptor, ionotropic kainate 5
UniProt
Q63273
Ligands
NAG, BMA
Pockets
5 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlutamate receptor, ionotropic kainate 5protein36937% helix, 20% strandQ63273

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 6 copies · chains A
  • BMA · beta-D-mannopyranose · sugar · chains A
  • GOL · Glycerol · additive · 3 copies · chains A
  • ACT · Acetate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16190.720.8076GOL
2850.360.7616empty
3540.340.7820empty
4590.340.7711empty
5590.280.7313empty

Modifications

Observed in the structure: 5 glycan, 3 disulfide (N-glycosylation, disulfide).

Compared structures

  • 3OM0 · Crystal structure of the GluK5 (KA2) ATD crystallographic dimer at 1.4 Angstrom resolution · the same entry in another collection · chain A against A, TM-score 1.00
  • Q63273 · AlphaFold monomer V2.0 prediction for glutamate receptor ionotropic, kainate 5 (Q63273) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.